A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia

Affiliations

• ¹ The Ottawa Blood Disease Centre, Division of Hematology and Department of Medicine, University of Ottawa and The Ottawa Hospital, Ottawa, ON, Canada;
• ² The Ottawa Blood Disease Centre, Division of Hematology and Department of Medicine, University of Ottawa and The Ottawa Hospital, Ottawa, ON, Canada; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada;
• ³ Department of Medicine, University of Turku and Turku University Hospital, Turku, Finland;
• ⁴ A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy;
• ⁵ Clinical Trial Centre, University of Leipzig, Leipzig, Germany;
• ⁶ Department of Obstetrics and Gynecology, Friedrich Schiller University Hospital, Jena, Germany;
• ⁷ LifeQuest Centre for Reproductive Medicine, Toronto, ON, Canada; Department of Medicine and Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON, Canada; and.
• ⁸ The Ottawa Blood Disease Centre, Division of Hematology and Department of Medicine, University of Ottawa and The Ottawa Hospital, Ottawa, ON, Canada; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada; Department of Obstetrics and Gynecology, University of Ottawa and The Ottawa Hospital, Ottawa, ON, Canada.